National Heart, Lung, and Blood Institute workshop: Improving outcomes for pulmonary vascular disease

Circulation

Volumn 125, Issue 17, 2012, Pages 2165-2170

  Robbins, Ivan M ^a   Moore, Timothy M ^b   Blaisdell, Carol J ^b   Abman, Steven H ^c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c Children's Hospital Colorado   (United States)

Author keywords

Clinical trials; Pediatrics; Pulmonary hypertension; Pulmonary vascular changes

Indexed keywords

ACETYLSALICYLIC ACID; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; PROSTANOID; WARFARIN;

ARTICLE; BLOOD VESSEL TONE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CONGENITAL DIAPHRAGM HERNIA; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; CYSTIC FIBROSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DOWN SYNDROME; ECHOCARDIOGRAPHY; HEART FAILURE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; IDIOPATHIC DISEASE; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS HYPOVENTILATION; LUNG DYSPLASIA; LUNG VASCULAR RESISTANCE; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; OBESITY; PATHOPHYSIOLOGY; PERSISTENT PULMONARY HYPERTENSION; PHASE 1 CLINICAL TRIAL (TOPIC); PHENOTYPE; PORTAL HYPERTENSION; PRIORITY JOURNAL; PULMONARY CAPILLARY HEMANGIOMATOSIS; PULMONARY HYPERTENSION; PULMONARY VENO-OCCLUSIVE DISEASE; SCLERODERMA; SICKLE CELL ANEMIA; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SURVIVAL RATE; WORKSHOP; WORLD HEALTH ORGANIZATION;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; CHILD; CLINICAL TRIALS AS TOPIC; FORECASTING; HUMANS; HYPERTENSION, PULMONARY; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (U.S.); PHENOTYPE; PROGNOSIS; RESEARCH; UNITED STATES; VASCULAR RESISTANCE;

EID: 84860329969     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.092924     Document Type: Article

References (11)

1. Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, Elliott CG, Gaine SP, Gladwin MT, Jing ZC, Krowka MJ, Langleben D, Nakanishi N, Souza R. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54:S43-S54.
2. Cerro MJ, Abman S, Diaz G, Freudenthal AH, Freudenthal F, Harikrishnan S, Haworth SG, Ivy D, Lopes AA, Raj JU, Sandoval J, Stenmark K, Adatia I. A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ. 2011;1:286-298.
3. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Simonneau G. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med. 2006;173:1023-1030.
4. Machado RD, Eickelberg O, Elliott CG, Geraci MW, Hanaoka M, Loyd JE, Newman JH, Phillips JA III, Soubrier F, Trembath RC, Chung WK. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol. 2009;54:S32-S42.
5. Mathai SC, Hassoun PM. Pulmonary arterial hypertension associated with systemic sclerosis. Expert Rev Respir Med. 2011;5:267-279.
6. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, Levy PC, Reid LM, Vreim CE, and Williams GW. Primary pulmonary hypertension. A national prospective study. Ann Intern Med. 1987;107:216-223.
7. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, Gressin V, Yaici A, Weitzenblum E, Cordier JF, Chabot F, Dromer C, Pison C, Reynaud-Gaubert M, Haloun A, Laurent M, Hachulla E, Cottin V, Degano B, Jais X, Montani D, Souza R, Simonneau G. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122:156-163.
8. Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006. Heart. 2009;95:312-317.
9. Fraisse A, Jais X, Schleich JM, di Filippo S, Maragnes P, Beghetti M, Gressin V, Voisin M, Dauphin C, Clerson P, Godart F, Bonnet D. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. Arch Cardiovasc Dis. 2010;103:66-74.
10. Mauritz GJ, Rizopoulos D, Groepenhoff H, Tiede H, Felix J, Eilers P, Bosboom J, Postmus PE, Westerhof N, Vonk-Noordegraaf A. Usefulness of serial N-terminal pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2011;108:1645-1650.
11. Ventetuolo CE, Benza RL, Peacock AJ, Zamanian RT, Badesch DB, Kawut SM. Surrogate and combined end points in pulmonary arterial hypertension. Proc Am Thorac Soc. 2008;5:617-622.